IBS Microbiome: Gut Flora in Irritable Bowel Syndrome

What Is the Irritable Bowel Syndrome Microbiome?

The term irritable bowel syndrome (IBS) microbiome refers to the community of microorganisms residing in the gut of individuals with irritable bowel syndrome. The human gut microbiome consists of trillions of bacteria, viruses, fungi, and other microorganisms that collectively play a crucial role in digestion, immune function, and overall health. In people with IBS, this microbial community is often altered in composition and diversity -- a condition known as dysbiosis.

The Link Between the Microbiome and Irritable Bowel Syndrome

Irritable bowel syndrome is a functional gastrointestinal disorder characterized by recurring abdominal pain, bloating, diarrhea, constipation, or a combination of these symptoms. Although the exact causes remain incompletely understood, a disrupted gut-brain axis and an altered gut microbiome composition are considered central contributing factors.

• Reduced microbial diversity: Studies show that IBS patients often have lower microbial species diversity compared to healthy individuals.
• Altered bacterial balance: A shift in the ratio of certain bacterial groups is commonly observed, including a decrease in beneficial bacteria such as Lactobacillus and Bifidobacterium and an increase in potentially harmful bacteria.
• SIBO (Small Intestinal Bacterial Overgrowth): Overgrowth of bacteria in the small intestine is observed in a proportion of IBS patients and may worsen symptoms.

Causes of Dysbiosis in Irritable Bowel Syndrome

Several factors can disturb the balance of the gut microbiome and contribute to the development or worsening of IBS:

• Antibiotic use: Antibiotics can destroy both harmful and beneficial bacteria, potentially causing a lasting shift in the microbial balance.
• Dietary habits: A diet low in fiber and high in processed foods promotes an unfavorable gut flora.
• Stress and psychological burden: Chronic stress influences gut microbiome composition via the gut-brain axis.
• Infections: Acute gastrointestinal infections (gastroenteritis) can trigger post-infectious IBS.
• Genetic factors: Genetic predisposition can influence individual microbiome composition.

Symptoms Related to the IBS Microbiome

The symptoms partly driven by dysbiosis overlap significantly with the typical complaints of irritable bowel syndrome:

• Persistent or recurring abdominal pain and cramping
• Bloating and excessive gas production
• Diarrhea, constipation, or an alternation between both
• Feeling of incomplete bowel emptying
• Mucus in the stool
• General fatigue and malaise

Diagnosis and Assessment of the IBS Microbiome

The diagnosis of IBS is primarily clinical, based on the Rome IV criteria, which consider specific symptom patterns and their frequency. The following methods are available for assessing the microbiome:

• Stool microbiome analysis: Using modern sequencing techniques (e.g., 16S rRNA sequencing or metagenomics), the composition of gut bacteria can be analyzed in detail.
• Breath tests: Hydrogen and methane breath tests can indicate bacterial overgrowth in the small intestine (SIBO).
• Inflammatory markers: Fecal calprotectin helps distinguish inflammatory bowel disease from IBS.

It is important to note that microbiome analyses from stool samples do not yet play a standardized role in routine clinical diagnostics and are mainly used in research settings.

Treatment and Support of the IBS Microbiome

Treatment aims to restore the microbial balance in the gut and relieve the symptoms of irritable bowel syndrome:

Dietary Adjustments

A low-FODMAP diet -- reducing foods containing fermentable carbohydrates -- has been shown in clinical studies to effectively reduce symptoms and positively influence the microbiome. A fiber-rich diet with plenty of vegetables, legumes, and whole grains supports the growth of beneficial bacteria.

Probiotics

Probiotics are live microorganisms that, when administered in adequate amounts, can confer a health benefit. Specific strains such as Lactobacillus rhamnosus GG, Bifidobacterium infantis, and Saccharomyces boulardii have been studied for their efficacy in IBS. Results are promising, but effectiveness is strain-specific and not established for all probiotic products.

Prebiotics

Prebiotics are non-digestible dietary components that promote the growth and activity of beneficial gut bacteria. Examples include inulin, fructooligosaccharides (FOS), and galactooligosaccharides (GOS). Caution is advised in IBS patients, however, as certain prebiotics may also increase bloating.

Stress Management

Because stress has a significant impact on the gut microbiome, stress-reduction techniques -- such as mindfulness-based stress reduction (MBSR), yoga, cognitive behavioral therapy (CBT), and relaxation exercises -- are an important component of treatment.

Antibiotics (targeted use)

In confirmed cases of SIBO, the non-absorbable antibiotic rifaximin can be used to reduce bacterial overgrowth in the small intestine without significantly affecting the colon microbiome.

Fecal Microbiota Transplantation (FMT)

Fecal microbiota transplantation (FMT) -- the transfer of stool from a healthy donor to a recipient -- is currently being intensively studied for the treatment of IBS. Initial study results show promise, but the method is not yet approved as a standard therapy for this indication.

References

1. Simren M. et al. - Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut, 2013. DOI: 10.1136/gutjnl-2012-302167
2. Mearin F. et al. - Bowel Disorders. Gastroenterology, 2016. DOI: 10.1053/j.gastro.2016.02.031 (Rome IV Criteria)
3. World Gastroenterology Organisation (WGO) - Global Guidelines: Probiotics and Prebiotics. 2023. Available at: https://www.worldgastroenterology.org